Low Immunogenicity in Patients with Giant Cell Arteritis Treated with Tocilizumab: 3-Year Results from the Randomized Controlled Portion and the Open-Label Follow-Up of a Phase 3 Trial

被引：0
|
作者：
Stone, John H. [1 ]
Mallalieu, Navita L. [2 ]
Bao, Min [3 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02115 USA
[2] Roche Innovat Ctr, New York, NY USA
[3] Genentech Inc, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1924
引用
收藏
页数：3
相关论文
共 50 条
  • [21] HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMISED CONTROLLED TRIAL
    Strand, V.
    Dimonaco, S.
    Tuckwell, K.
    Klearman, M.
    Collinson, N.
    Stone, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1128 - 1129
  • [22] Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
    Strand, Vibeke
    Dimonaco, Sophie
    Tuckwell, Katie
    Klearman, Micki
    Collinson, Neil
    Stone, John H.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [23] Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
    Vibeke Strand
    Sophie Dimonaco
    Katie Tuckwell
    Micki Klearman
    Neil Collinson
    John H. Stone
    Arthritis Research & Therapy, 21
  • [24] A 3-year open-label, follow-up study to evaluate the efficacy and tolerability of sarizotan in Parkinson's disease patients
    Anow, C. Warren
    ANNALS OF NEUROLOGY, 2006, 60 : S80 - S80
  • [25] Immediate Postextractive Implants With and Without Bone Graft: 3-year Follow-up Results From a Multicenter Controlled Randomized Trial
    Mastrangelo, Filiberto
    Gastaldi, Giorgio
    Vinci, Raffaele
    Troiano, Giuseppe
    Tettamanti, Lucia
    Gherlone, Enrico
    Lo Muzio, Lorenzo
    IMPLANT DENTISTRY, 2018, 27 (06) : 638 - 645
  • [26] Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
    Berge, Eivind
    Cohen, Geoffrey
    Roaldsen, Melinda B.
    Lundstrom, Erik
    Isaksson, Eva
    Rudberg, Ann-Sofie
    Slot, Karsten Bruins
    Forbes, John
    Smith, Joel
    Drever, Jonathan
    Wardlaw, Joanna M.
    Lindley, Richard I.
    Sandercock, Peter A. G.
    Whiteley, William N.
    LANCET NEUROLOGY, 2016, 15 (10): : 1028 - 1034
  • [27] PERCUTANEOUS BALLOON VS OPEN SURGICAL MITRAL COMMISSUROTOMY - 3-YEAR FOLLOW-UP OF A RANDOMIZED TRIAL
    TURI, ZG
    RAJU, BS
    RAJU, R
    REYES, V
    FROMM, B
    SINGH, S
    FARKAS, P
    STEPHENSON, LW
    WYNNE, J
    CIRCULATION, 1993, 88 (04) : 339 - 339
  • [28] Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial
    Motzer, Robert J.
    Escudier, Bernard
    George, Saby
    Hammers, Hans J.
    Srinivas, Sandhya
    Tykodi, Scott S.
    Sosman, Jeffrey A.
    Plimack, Elizabeth R.
    Procopio, Giuseppe
    McDermott, David F.
    Castellano, Daniel
    Choueiri, Toni K.
    Donskov, Frede
    Gurney, Howard
    Oudard, Stephane
    Richardet, Martin
    Peltola, Katriina
    Alva, Ajjai S.
    Carducci, Michael
    Wagstaff, John
    Chevreau, Christine
    Fukasawa, Satoshi
    Tomita, Yoshihiko
    Gauler, Thomas C.
    Kollmannsberger, Christian K.
    Schutz, Fabio A.
    Larkin, James
    Cella, David
    McHenry, M. Brent
    Saggi, Shruti Shally
    Tannir, Nizar M.
    CANCER, 2020, 126 (18) : 4156 - 4167
  • [29] Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Median 3-year follow-up
    Smith, Angela
    Nix, Jeffrey W.
    Nielsen, Matthew Edward
    Wallen, Eric
    Pruthi, Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [30] CHARACTERISTICS OF GIANT CELL ARTERITIS FLARES AFTER SUCCESSFUL TREATMENT WITH TOCILIZUMAB: RESULTS FROM THE LONG-TERM EXTENSION OF A RANDOMIZED CONTROLLED PHASE 3 TRIAL
    Unizony, S.
    Mohan, S.
    Han, J.
    Stone, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 656 - 657
12345